Prevalence of soluble peptidylarginine deiminase 4 (PAD4) and anti-PAD4 antibodies in autoimmune diseases-Reference-Cited by-同舟云学术

Prevalence of soluble peptidylarginine deiminase 4 (PAD4) and anti-PAD4 antibodies in autoimmune diseases

Published:2015-09-29 Issue:5 Volume:35 Page:1181-1188
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Umeda Naoto,Matsumoto Isao,Kawaguchi Hoshimi,Kurashima Yuko,Kondo Yuya,Tsuboi Hiroto,Ogishima Hiroshi,Suzuki Takeshi,Kagami Yayoi,Sakyu Takuya,Ishigami Akihito,Maruyama Naoki,Sumida Takayuki

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

http://link.springer.com/content/pdf/10.1007/s10067-015-3082-z.pdf

Reference22 articles.

1. Suwannalai P, Trouw LA, Toes RE, Huizinga TW (2012) Anti-citrullinated protein antibodies (ACPA) in early rheumatoid arthritis. Mod Rheumatol 22:15–20

2. Suzuki A, Yamada R, Chang X et al (2003) Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet 34:395–402

3. Ikari K, Kuwahara M, Nakamura T et al (2005) Association between PADI4 and rheumatoid arthritis: a replication study. Arthritis Rheum 52:3054–7

4. Kang CP, Lee HS, Ju H, Cho H, Kang C, Bae SC (2006) A functional haplotype of the PADI4 gene associated with increased rheumatoid arthritis susceptibility in Koreans. Arthritis Rheum 54:90–6

5. Hou S, Gao GP, Zhang XJ et al (2013) PADI4 polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis. Mod Rheumatol 23:50–60

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Screening of peptidyl arginine deiminase 4 inhibitors in traditional herbal medicines;Fitoterapia;2024-09

2. Determination of the derivatization reactivity between <italic>α/β</italic>-dicarbonyl compounds and standard citrullinated peptides based on matrix-assisted laser desorption ionization-time-of-flight mass spectrometry;Chinese Journal of Chromatography;2024-07-01

3. Diagnostic values, association with disease activity and possible risk factors of anti-PAD4 in rheumatoid arthritis: a meta-analysis;Rheumatology;2023-10-12

4. Serum Autoantibody Biomarkers for Management of Rheumatoid Arthritis Disease;Biosensors;2023-03-13

5. Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies;Cells;2021-11-04